We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Top Buys

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$55.3M
2
AAPL icon
Apple
AAPL
+$33.2M
3
AMZN icon
Amazon
AMZN
+$29.2M
4
MSFT icon
Microsoft
MSFT
+$26.4M
5
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$22.1M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$93.3M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$86M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$51.5M
5
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.77%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRAH
151
DELISTED
PRA Health Sciences, Inc.
PRAH
$2.72M 0.11%
27,931
+25,953
+1,312% +$2.42M
CRL icon
152
Charles River Laboratories
CRL
$12.8B
$2.72M 0.11%
15,573
+13,854
+806% +$2.21M
AVGO icon
153
Broadcom
AVGO
$2T
$2.67M 0.11%
84,490
+23,760
+39% +$665K
XSLV icon
154
Invesco S&P SmallCap Low Volatility ETF
XSLV
$247M
$2.66M 0.11%
78,652
+19,060
+32% +$633K
VBK icon
155
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.9B
$2.66M 0.11%
13,333
+9,010
+208% +$1.63M
FVD icon
156
First Trust Value Line Dividend Fund
FVD
$8.38B
$2.64M 0.11%
86,989
+43,489
+100% +$1.29M
RGEN icon
157
Repligen
RGEN
$9B
$2.64M 0.11%
21,325
+21,168
+13,483% +$2.49M
DYNF icon
158
BlackRock US Equity Factor Rotation ETF
DYNF
$39.8B
$2.61M 0.11%
99,721
+78,750
+376% +$1.97M
ETSY icon
159
Etsy
ETSY
$7.81B
$2.61M 0.11%
24,560
+22,501
+1,093% +$1.66M
GIS icon
160
General Mills
GIS
$19.3B
$2.59M 0.11%
42,041
+40,192
+2,174% +$2.42M
POOL icon
161
Pool Corp
POOL
$7.31B
$2.58M 0.11%
+9,496
New +$2.2M
LNC icon
162
Lincoln National
LNC
$8.93B
$2.58M 0.11%
70,166
+70,126
+175,315% +$2.47M
CACI icon
163
CACI
CACI
$13.9B
$2.56M 0.11%
11,802
+10,945
+1,277% +$2.62M
T icon
164
AT&T
T
$162B
$2.56M 0.1%
112,008
-10,804
-9% -$246K
TECH icon
165
Bio-Techne
TECH
$11.2B
$2.55M 0.1%
38,676
+33,848
+701% +$2.03M
PSL icon
166
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$84.8M
$2.54M 0.1%
39,062
+17,436
+81% +$1.09M
FISV
167
Fiserv Inc
FISV
$28.9B
$2.53M 0.1%
25,955
+25,892
+41,098% +$2.61M
TDOC icon
168
Teladoc Health
TDOC
$1.21B
$2.53M 0.1%
13,273
+9,583
+260% +$1.68M
LIN icon
169
Linde
LIN
$226B
$2.52M 0.1%
11,899
+11,799
+11,799% +$2.28M
STLD icon
170
Steel Dynamics
STLD
$37.5B
$2.5M 0.1%
96,002
+88,496
+1,179% +$2.21M
KO icon
171
Coca-Cola
KO
$374B
$2.49M 0.1%
+55,711
New +$2.57M
GNRC icon
172
Generac Holdings
GNRC
$12.5B
$2.49M 0.1%
+20,406
New +$2.15M
GS icon
173
Goldman Sachs
GS
$301B
$2.48M 0.1%
12,529
-7,507
-37% -$1.41M
VEA icon
174
Vanguard FTSE Developed Markets ETF
VEA
$234B
$2.47M 0.1%
+63,659
New +$2.32M
AMED
175
DELISTED
Amedisys
AMED
$2.46M 0.1%
12,388
+12,382
+206,367% +$2.31M
5 6
7
8 9

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.